CRISPR Therapeutics AG (CRSP)

NASDAQ: CRSP · Real-Time Price · USD

53.39

+2.95 (5.85%)

At close: Oct 9, 2026, 4:00 PM EDT

53.69

+0.30 (0.56%)

After-hours: Oct 9, 2026, 7:57 PM EDT

CRISPR Therapeutics AG Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	5,162	4,998	3,360	4,972	3,183	5,799
Market Cap Growth	-26.07%	48.76%	-32.44%	56.24%	-45.12%	-46.39%
Enterprise Value	3,582	3,264	1,651	3,474	1,452	3,527
Last Close Price	53.39	52.44	39.36	62.60	40.65	75.78

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	-	-	15.36
PS Ratio	385.49	1423.80	90.03	13.40	2656.64	6.34
PB Ratio	2.95	2.60	1.74	2.64	1.70	2.42
P/TBV Ratio	2.96	2.60	1.74	2.64	1.70	2.42
P/FCF Ratio	-	-	-	-	-	12.68
P/OCF Ratio	-	-	-	-	-	10.76

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	267.46	930.04	44.26	9.36	1211.76	3.86
EV/EBITDA Ratio	-	-	-	-	-	9.01
EV/EBIT Ratio	-	-	-	-	-	9.44
EV/FCF Ratio	-	-	-	-	-	7.71

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.45	0.11	0.12	0.13	0.13	0.09
Debt / EBITDA Ratio	-	-	-	-	-	0.53
Debt / FCF Ratio	-	-	-	-	-	0.49
Net Debt / Equity Ratio	-0.90	-0.92	-0.87	-0.77	-0.87	-0.90
Net Debt / EBITDA Ratio	3.08	3.22	3.76	7.19	2.50	-5.50
Net Debt / FCF Ratio	4.26	5.11	11.61	5.40	3.05	-4.71
Asset Turnover	0.01	0.00	0.02	0.17	0	0.40
Quick Ratio	17.79	13.25	21.97	17.47	15.08	19.92
Current Ratio	17.85	13.32	22.07	17.54	15.30	20.17
Return on Equity (ROE)	-26.10%	-30.18%	-19.20%	-8.17%	-30.42%	18.59%
Return on Assets (ROA)	-14.20%	-15.76%	-13.04%	-6.22%	-16.85%	10.20%
Return on Invested Capital (ROIC)	-325.94%	-280.87%	-137.29%	-60.81%	-244.99%	264.84%
Return on Capital Employed (ROCE)	-21.10%	-26.90%	-21.70%	-10.50%	-31.70%	14.20%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-8.74%	-11.64%	-10.90%	-3.09%	-20.43%	6.51%
FCF Yield	-7.19%	-6.92%	-4.31%	-5.43%	-16.74%	7.89%
Buyback Yield / Dilution	-10.33%	-6.60%	-6.49%	-1.90%	3.29%	-21.90%

SEC Filings: 10-K · 10-Q